Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose for Skeletal Muscle Metabolism in Heart Failure
NCT03218384Phase 2Terminated
- Sponsor
- NYU Langone Health
- Start
- Sep 2017
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by NYU Langone Health. Started Sep 2017; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03218384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03218384.